Literature DB >> 22093942

Corin in clinical laboratory diagnostics.

Ningzheng Dong1, Shenghan Chen, Wei Wang, Yiqing Zhou, Qingyu Wu.   

Abstract

Corin is a transmembrane serine protease identified in the heart, where it converts natriuretic peptides from inactive precursors to mature active forms. Studies in animal models and patients with hypertension and heart disease demonstrate that corin is critical in maintaining normal blood pressure and cardiac function. Like many proteolytic enzymes, corin expression and activity are regulated. Cell biology experiments indicate that transcriptional control, intracellular protein trafficking, cell surface targeting, zymogen activation and ectodomain shedding are important mechanisms in regulating corin expression and activity in the heart. More recently, soluble corin was detected in human blood and its levels were found to be reduced in patients with heart failure (HF). These findings indicate that corin deficiency may be involved in the pathogenesis of HF and suggest that soluble corin may be used as a biomarker for the disease. In this review, we describe the function and regulation of corin and discuss recent studies of soluble corin in human blood and its potential use as a biomarker for HF.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22093942      PMCID: PMC3246062          DOI: 10.1016/j.cca.2011.10.032

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  95 in total

1.  Differences in neurogenic potential in floor plate cells along an anteroposterior location: midbrain dopaminergic neurons originate from mesencephalic floor plate cells.

Authors:  Yuichi Ono; Tomoya Nakatani; Yoshimasa Sakamoto; Eri Mizuhara; Yasuko Minaki; Minoru Kumai; Akiko Hamaguchi; Miyuki Nishimura; Yoko Inoue; Hideki Hayashi; Jun Takahashi; Toshio Imai
Journal:  Development       Date:  2007-08-01       Impact factor: 6.868

2.  Heart failure: a state of brain natriuretic peptide deficiency or resistance or both!

Authors:  Horng H Chen
Journal:  J Am Coll Cardiol       Date:  2007-02-26       Impact factor: 24.094

Review 3.  Hepsin and prostate cancer.

Authors:  Qingyu Wu; Gordon Parry
Journal:  Front Biosci       Date:  2007-09-01

4.  Corin I555(P568) allele is associated with enhanced cardiac hypertrophic response to increased systemic afterload.

Authors:  J Eduardo Rame; Mark H Drazner; Wendy Post; Ronald Peshock; Joao Lima; Richard S Cooper; Daniel L Dries
Journal:  Hypertension       Date:  2007-02-12       Impact factor: 10.190

5.  Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA.

Authors:  Kate A Owen; Deyi Qiu; Juliano Alves; Andrew M Schumacher; Lynette M Kilpatrick; Jun Li; Jennifer L Harris; Vincent Ellis
Journal:  Biochem J       Date:  2010-02-09       Impact factor: 3.857

Review 6.  The serine protease corin in cardiovascular biology and disease.

Authors:  Qingyu Wu
Journal:  Front Biosci       Date:  2007-05-01

Review 7.  Molecular forms of natriuretic peptides in heart failure and their implications.

Authors:  Ye Olivia Xu-Cai; Qingyu Wu
Journal:  Heart       Date:  2009-05-17       Impact factor: 5.994

Review 8.  Matriptase-dependent cell surface proteolysis in epithelial development and pathogenesis.

Authors:  Thomas H Bugge; Karin List; Roman Szabo
Journal:  Front Biosci       Date:  2007-09-01

9.  Plasma soluble corin in patients with heart failure.

Authors:  Ningzheng Dong; Shenghan Chen; Junhua Yang; Lizhen He; Peng Liu; Dongdong Zheng; Lin Li; Yiqing Zhou; Changgeng Ruan; Edward Plow; Qingyu Wu
Journal:  Circ Heart Fail       Date:  2010-01-08       Impact factor: 8.790

10.  Evidence for functional heterogeneity of circulating B-type natriuretic peptide.

Authors:  Faquan Liang; Jessica O'Rear; Ute Schellenberger; Lungkuo Tai; Michael Lasecki; George F Schreiner; Fred S Apple; Alan S Maisel; N Stephen Pollitt; Andrew A Protter
Journal:  J Am Coll Cardiol       Date:  2007-02-26       Impact factor: 24.094

View more
  26 in total

1.  Plasma corin decreases after coronary artery bypass graft surgery and is associated with postoperative heart failure: a pilot study.

Authors:  Caryn S Barnet; Xiaoxia Liu; Simon C Body; Charles D Collard; Stanton K Shernan; Jochen D Muehlschlegel; Petr Jarolim; Amanda A Fox
Journal:  J Cardiothorac Vasc Anesth       Date:  2014-11-11       Impact factor: 2.628

Review 2.  Corin in natriuretic peptide processing and hypertension.

Authors:  Yiqing Zhou; Qingyu Wu
Journal:  Curr Hypertens Rep       Date:  2014-02       Impact factor: 5.369

Review 3.  BNP molecular forms and processing by the cardiac serine protease corin.

Authors:  Tomoko Ichiki; Brenda K Huntley; John C Burnett
Journal:  Adv Clin Chem       Date:  2013       Impact factor: 5.394

Review 4.  Role of corin in the regulation of blood pressure.

Authors:  Hui Li; Yue Zhang; Qingyu Wu
Journal:  Curr Opin Nephrol Hypertens       Date:  2017-03       Impact factor: 2.894

5.  Fibrosis and Fibrotic Gene Expression in Pediatric and Adult Patients With Idiopathic Dilated Cardiomyopathy.

Authors:  Kathleen C Woulfe; Austine K Siomos; Hieu Nguyen; Megan SooHoo; Csaba Galambos; Brian L Stauffer; Carmen Sucharov; Shelley Miyamoto
Journal:  J Card Fail       Date:  2016-11-24       Impact factor: 5.712

6.  Localization of corin and atrial natriuretic peptide expression in human renal segments.

Authors:  Liang Dong; Hao Wang; Ningzheng Dong; Ce Zhang; Boxin Xue; Qingyu Wu
Journal:  Clin Sci (Lond)       Date:  2016-06-24       Impact factor: 6.124

7.  Corin mutation R539C from hypertensive patients impairs zymogen activation and generates an inactive alternative ectodomain fragment.

Authors:  Ningzheng Dong; Chaodong Fang; Yizhi Jiang; Tiantian Zhou; Meng Liu; Jianping Zhou; Jianzhong Shen; Koichi Fukuda; Jun Qin; Qingyu Wu
Journal:  J Biol Chem       Date:  2013-01-31       Impact factor: 5.157

Review 8.  Role of corin and atrial natriuretic peptide in preeclampsia.

Authors:  Y Zhou; Q Wu
Journal:  Placenta       Date:  2012-12-02       Impact factor: 3.481

9.  Corin mutations K317E and S472G from preeclamptic patients alter zymogen activation and cell surface targeting. [Corrected].

Authors:  Ningzheng Dong; Tiantian Zhou; Yue Zhang; Meng Liu; Hui Li; Xiaoyi Huang; Zhenzhen Liu; Yi Wu; Koichi Fukuda; Jun Qin; Qingyu Wu
Journal:  J Biol Chem       Date:  2014-05-14       Impact factor: 5.157

10.  Serum corin is reduced and predicts adverse outcome in non-ST-elevation acute coronary syndrome.

Authors:  Aviva Peleg; Diab Ghanim; Shiraz Vered; Yonathan Hasin
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.